Initiation of Antiviral Treatment in SARS-CoV2: Modeling Viral Dynamics and Drug Properties

CPT Pharmacometrics Syst Pharmacol. 2020 Sep;9(9):481-483. doi: 10.1002/psp4.12550. Epub 2020 Aug 27.

Authors

Daniel Scholes Rosenbloom¹, Ping Zhao², Vikram Sinha¹

Affiliations

¹ Quantitative Pharmacology and Pharmacometrics, Pharmacokinetics, Pharmacodynamics, and Drug Metabolism (PPDM), Merck & Co., Inc., Kenilworth, New Jersey, USA.
² The Bill & Melinda Gates Foundation, Seattle, Washington, USA.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antiviral Agents / pharmacology
COVID-19*
Humans
Pharmaceutical Preparations*
RNA, Viral
SARS-CoV-2
Viral Load

Substances

Antiviral Agents
Pharmaceutical Preparations
RNA, Viral